Data Insights
By Company Name
No Filter Selected
By Disease Name
No Filter Selected
By Drug Name
No Filter Selected
By Themes
No Filter Selected
Showing 1 results out of 1
Data Insights
AFA-281 by AfaSci for Inflammatory Pain: Likelihood of Approval
AFA-281 is under clinical development by AfaSci and currently in Phase I for Inflammatory Pain. According to GlobalData, Phase I...